Prostate Cancer: In Search of the Holy Grail
Professor Richard J Ablin (University of Arizona College of Medicine) will present a seminar entitled 'Prostate Cancer: In Search of the Holy Grail' on Thursday 12th May 2016 at 4:00pm in the UCD Conway Lecture Theatre.
- Refreshments will be served at 4.00pm.
- Lecture from 4.30 to 5.30pmwith a question and answer session to follow.
- World renowned cancer researcher (Michael) Joe Duffy and cancer patient advocate John Dowling will also be in attendance.
For more information and tickets visit the Lecture’s Eventbrite page.
About Prof Ablin
A Research Professor of Immunology and Pathology at University of Arizona College of Medicine, the Arizona Cancer Center and the BIO5 Institute, Professor Ablin discovered the prostate-specific antigen in 1970. He has been an outspoken critic of the widespread use of PSA in prostate cancer screening and has argued that the use of the PSA test may lead to overdiagnosis and overtreatment.
Prof Ablin was awarded a PhD at the State University of New York (SUNY) at Buffalo in 1967 where he continued as a postdoctoral fellow in microbiology and immunology until 1970. He has Board Certifications from the American Board of Clinical Immunology & Allergy (1971), the National Registry of Microbiologists of the American Academy of Microbiology (1973) and the American Society for Clinical Pathology Board of Registry (2005).
Prior to his current role of Research Professor of Immunology and Pathology at the University of Arizona College in the Arizona Cancer Centre, he was Director, Scientific Investigation at Tetragenex Pharmaceuticals Inc. and then Director, Immunobiology Unit within the Department of Urology in the Stony Brook School of Medicine at State University of New York.
He is founding President of the Robert Benjamin Ablin Foundation for Cancer Research, founded in memory of his father in 1979. He was a founding member and Vice President (1977-80) of the American College of Cryosurgery and served as President (1977-80) of the International Society of Cryosurgery of which he is Honorary Life-Time President since 1980. Prof Ablin is a Diplomat of the American Board of Clinical Immunology and Allergy, and a member of the American Associations for Cancer Research, of Immunologists, the British Association of Surgical Oncology, and the New York Academy of Sciences.
Prof Ablin has received numerous honour and awards as a researcher and an educator throughout his career. He was nominated for the Lasker Award in 1997 for his discovery of prostate-specific antigen and was recognised by University of Buffalo with a Distinguished Alumni Award in 2010.